Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. The company provides breast cancer predictive assessment; multi-pathology predictive assessment; and the Care4Eat solution, a nutrition assessment that allows employees to take stock of their eating habits and benefit from rebalancing and personalized advice. It also offers MammoRisk, a breast cancer prediction test based on the patient’s individual risk; and DenSeeMammo, a breast density measurement software. Predilife S.A. was incorporated in 2004 and is headquartered in Villejuif, France.
Metrics to compare | ALPRE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALPREPeersSector | |
---|---|---|---|---|
P/E Ratio | −3.0x | −2.5x | −0.5x | |
PEG Ratio | −5.36 | 0.05 | 0.00 | |
Price/Book | −1.0x | 1.7x | 2.6x | |
Price / LTM Sales | 25.9x | 3.3x | 3.3x | |
Upside (Analyst Target) | - | 137.7% | 43.5% | |
Fair Value Upside | Unlock | 16.3% | 6.9% | Unlock |